Abstract
The present invention relates to compound according to formula (I), which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role.
Full Text
What is claimed is:
The present invention relates to compound according to formula (I),
which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role.
Timeline
Filed
05/04/2026Published
09/10/2026Granted
Not AvailableIPC Codes(1)
C07D 401/06:linked by a carbon chain containing only aliphatic carbon atoms